Nerve News and Research

RSS

Existing drug that targets sleeping cells could hold the key to treating lower back pain

An existing drug that targets senescent, or sleeping cells could provide the answer to treating lower back pain, according to a new study.

14 Nov 2023

Does cannabis use impact the risk of glaucoma? New study investigates

The study in Scientific Reports finds no significant association between cannabis use and the risk of primary open-angle glaucoma, challenging the notion that cannabis could influence intraocular pressure and glaucoma risk.

14 Nov 2023

Study reveals early role of SYNGAP1 gene in brain development

The gene SYNGAP1, the variants of which are top risk factors for Autism Spectrum Disorder (ASD), has previously unappreciated effects on the developing brain, according to a new study published in Nature Neuroscience.

9 Nov 2023

NYU Langone Health performs the world's first whole-eye and partial-face transplant for military veteran

A surgical team from NYU Langone Health performed the world's first whole-eye and partial-face transplant for a 46-year-old military veteran from Arkansas who survived a work-related high-voltage electrical accident.

9 Nov 2023

Study shows depression increases disability risk in rheumatoid arthritis sufferers

The interactions between rheumatoid arthritis (RA) and major depressive disorder (MDD).

7 Nov 2023

Gut health linked to Alzheimer's disease progression, experts urge dietary shift

The interactions between the gut microbiome, lipids, and Alzheimer’s disease (AD).

7 Nov 2023

Blood test predicts MS disability worsening up to two years in advance

Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening disability one to two years later, according to a new study spearheaded by researchers at UC San Francisco.

6 Nov 2023

AI predicts glaucoma progression in high-risk patients with high accuracy

AI (artificial intelligence) that is trained to recognize red flags in retinal images and clinical information can predict if and when people at high risk of glaucoma, usually referred to as 'glaucoma suspects,' go on to actually develop it, finds research published online in the British Journal of Ophthalmology.

3 Nov 2023

Citrus compounds show zesty promise in type 2 diabetes management

Citrus compounds show promise in type 2 diabetes management, reducing blood glucose and mitigating metabolic complications without a clear threshold in humans for bioflavonoid efficacy.

2 Nov 2023

Synthetic melanin cream heals skin damage and promotes repair

Imagine a skin cream that heals damage occurring throughout the day when your skin is exposed to sunlight or environmental toxins.

2 Nov 2023

Cancer neuroscience: A new frontier in cancer treatment

Cancer cells hijack normal biological processes, allowing them to multiply. For example, tumors spur construction of new blood vessels, building themselves "highways" to supply nutrients.

1 Nov 2023

Pulsed field ablation safe and effective for women with atrial fibrillation

Women with atrial fibrillation (AF) undergoing a procedure called pulsed field ablation (PFA) have just as good outcomes as men with AF undergoing the same procedure, according to a large-scale international study led by the Icahn School of Medicine at Mount Sinai.

1 Nov 2023

Clinical trial demonstrates the effectiveness of ALS drug in treating people with acute spinal cord injuries

A small clinical trial with a pharmacokinetic sub-study, led by a world-renowned pharmacologist at the University of Houston, has demonstrated the promising effectiveness of the drug Riluzole for improving functionality in people with acute spinal cord injuries (SCI) if the drug is taken within 12 hours post-injury.

1 Nov 2023

New drug shows promise in killing cancer cells with genetic vulnerability

Imagine the body's cells are well-behaved students in the classroom. The "teachers" are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes are away, cells may go astray.

1 Nov 2023

New insights into role of cholinergic centro-cingulate network in Parkinson's disease and normal aging

A new research perspective was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 20, entitled, "Cholinergic centro-cingulate network in Parkinson disease and normal aging."

1 Nov 2023

Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies

Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications.

1 Nov 2023

3D organization of DNA can influence glioblastoma progression, study reveals

A pioneering study at Umeå University, Sweden, has unveiled that the 3D organization of DNA can influence the progression of the aggressive brain tumor known as glioblastoma.

1 Nov 2023

UTA biology professor awarded NIH grant for new super-resolution microscope

UTA will soon add a new piece of cutting-edge equipment to its already impressive and growing research armamentarium-;a type of super-resolution microscope (SRM) that allows biologists to see structures within a cell in even finer detail.

31 Oct 2023

Spicing up memory: Wasabi found to boost brainpower in seniors

A 12-week study on adults over 60 found that wasabi supplements containing 6-MSITC significantly improved episodic and working memory. While other cognitive domains showed no improvement, the findings suggest that wasabi's anti-inflammatory and anti-oxidant properties may offer new avenues for combating age-related memory decline.

31 Oct 2023

Axon Biology & The Future of Drug Discovery: A Deep Dive with Dr Federico Dajas-Bailador

News-Medical sits down with Dr. Federico Dajas-Bailador, a leading expert in axon biology and drug discovery.

From ELRIG (UK) Ltd. 31 Oct 2023

Nerve News and Research

Existing drug that targets sleeping cells could hold the key to treating lower back pain

Does cannabis use impact the risk of glaucoma? New study investigates

Study reveals early role of SYNGAP1 gene in brain development

NYU Langone Health performs the world's first whole-eye and partial-face transplant for military veteran

Study shows depression increases disability risk in rheumatoid arthritis sufferers

Gut health linked to Alzheimer's disease progression, experts urge dietary shift

Blood test predicts MS disability worsening up to two years in advance

AI predicts glaucoma progression in high-risk patients with high accuracy

Citrus compounds show zesty promise in type 2 diabetes management

Synthetic melanin cream heals skin damage and promotes repair

Cancer neuroscience: A new frontier in cancer treatment

Pulsed field ablation safe and effective for women with atrial fibrillation

Clinical trial demonstrates the effectiveness of ALS drug in treating people with acute spinal cord injuries

New drug shows promise in killing cancer cells with genetic vulnerability

New insights into role of cholinergic centro-cingulate network in Parkinson's disease and normal aging

Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies

3D organization of DNA can influence glioblastoma progression, study reveals

UTA biology professor awarded NIH grant for new super-resolution microscope

Spicing up memory: Wasabi found to boost brainpower in seniors

Axon Biology & The Future of Drug Discovery: A Deep Dive with Dr Federico Dajas-Bailador

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News